{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:50:58Z","timestamp":1793397058969,"version":"4.5.0"},"reference-count":47,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T00:00:00Z","timestamp":1209859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The purpose of this article is to provide a systematic overview of the literature on adrenal suppression and Cushing's syndrome secondary to an interaction between inhaled\/intranasal fluticasone and ritonavir. The clinical presentation, diagnosis and management will be discussed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A literature search using Medline and EMBASE and a search of abstracts of the three previous years of major HIV\u2010related conferences were carried out.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 25 cases (15 adult and 10 paediatric) of significant adrenal suppression secondary to an interaction between ritonavir and inhaled fluticasone, and three cases involving ritonavir and intranasal fluticasone. Cases with other steroids were not reported; however, there were cases of adrenal suppression with itraconazole [also a potent cytochrome p (CYP) 3A4 inhibitor] and inhaled budesonide. Clinicians need to differentiate between antiretroviral\u2010induced lipodystrophy syndrome and iatrogenic Cushing's syndrome secondary to glucocorticoid use. Long\u2010term fluticasone and ritonavir should be avoided. If ritonavir is required, another inhaled steroid such as low\u2010dose budesonide or beclomethasone can be used cautiously. Upon discontinuation of inhaled corticosteroids, close monitoring for symptoms of adrenal insufficiency is warranted. The need for steroid replacement therapy at physiological doses should be assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The combination of ritonavir and fluticasone should be avoided. Budesonide, beclomethasone, triamcinolone and flunisolide appear to be safer options.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2008.00579.x","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T07:07:37Z","timestamp":1209971257000},"page":"389-396","source":"Crossref","is-referenced-by-count":141,"title":["Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature"],"prefix":"10.1111","volume":"9","author":[{"given":"MM","family":"Foisy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EMK","family":"Yakiwchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AE","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,8]]},"reference":[{"key":"e_1_2_5_2_2","unstructured":"Abbott Laboratories. Norvir (ritonavir) package insert. North Chicago IL;2006."},{"key":"e_1_2_5_3_2","first-page":"274","article-title":"Cushing's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone","volume":"75","author":"Chen F","year":"1999","journal-title":"Sex Transm Infect"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199909100-00038"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2001.0928"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/342562"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2003.00149.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2004.00723.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000166102.21391.81"},{"key":"e_1_2_5_10_2","first-page":"4394","article-title":"Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus\u2010infected patients receiving inhaled corticosteroids and ritonavir\u2010boosted protease inhibitors","volume":"90","author":"Samaras K","year":"2005","journal-title":"six cases"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1081\/JAS-200038366"},{"key":"e_1_2_5_12_2","unstructured":"FoisyM ChiuI SinghA.Cushing's syndrome due to an interaction between lopinavir\/ritonavir and fluticasone.16th Annual Canadian Conference on HIV\/AIDS Research. Toronto Ontario Canada.April 2007[Abstract P160]."},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.11.034"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000242929.95258.69"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328013d9c7"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K075"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2006.0117"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.115563"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17014"},{"key":"e_1_2_5_20_2","first-page":"356","article-title":"How the lung handles drugs","volume":"1","author":"Winkler J","year":"2004","journal-title":"pharmacokinetics and pharmacodynamics of inhaled corticosteroids"},{"key":"e_1_2_5_21_2","unstructured":"GlaxoSmithKline and Abbott Laboratories Public Safety Information January 2004. Available from:http:\/\/www.hc\u2010sc.gc.ca\/hpfb\u2010dgpsa\/tpd\u2010dpt\/fluticasone_propionate\u2010ritonavir_hpc_e.html. Accessed April 3 2007."},{"key":"e_1_2_5_22_2","unstructured":"Health Canada Public Safety Information. Available from:http:\/\/www.hc\u2010sc.gc.ca\/dhp\u2010mps\/alt_formats\/hpfb\u2010dgpsa\/pdf\/medeff\/fluticasone_ritonavir_pa\u2010ap_e.pdf. Accessed May 6 2007."},{"key":"e_1_2_5_23_2","unstructured":"U.S. Food and Drug Administration: Medwatch. Available from:http:\/\/www.fda.gov\/medwatch\/SAFETY\/2005\/mar05.htm. Accessed May 6 2007."},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200205240-00017"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2001.00058.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)80217-X"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70156-3"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.6.457"},{"key":"e_1_2_5_29_2","first-page":"960","article-title":"Inhaled fluticasone propionate and adrenal effects in adult asthma","volume":"28","author":"Masoli M","year":"2006","journal-title":"systematic review and meta-analysis"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62056-X"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7539.469"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.8.749"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D222"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2002.tb02894.x"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(03)00022-5"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03190632"},{"key":"e_1_2_5_37_2","first-page":"34","article-title":"Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults","volume":"7","author":"Dyer MJ","year":"2006","journal-title":"a systematic review"},{"key":"e_1_2_5_38_2","first-page":"201","article-title":"Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide","volume":"12","author":"Rohatagi S.","year":"2005","journal-title":"Am J Ther"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.5414\/CPP43264"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80113-2"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/367566"},{"key":"e_1_2_5_42_2","first-page":"294","article-title":"Ritonavir and fluticasone","volume":"148","author":"Li AM.","year":"2006","journal-title":"beware of this potentially fatal combination"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68699-6"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.2.236"},{"key":"e_1_2_5_45_2","unstructured":"NiemanLK.Diagnosis of adrenal insufficiency. In: UpToDate Rose BD (Ed.) UpToDate Waltham MA2007. Available from:http:\/\/www.uptodate.com. Accessed June 8 2007."},{"key":"e_1_2_5_46_2","first-page":"521","article-title":"Safely withdrawing patients from chronic glucocorticoid therapy","volume":"55","author":"Kountz D","year":"1997","journal-title":"Am Fam Phys"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2005.01.013"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000187444.38461.70"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2008.00579.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2008.00579.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T19:03:51Z","timestamp":1696878231000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2008.00579.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1468-1293.2008.00579.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00579.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}